Talk:TNFRSF18
Appearance
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||
|
GITR is a drug target
[edit][1] says INCAGN1876 is an agonist antibody targeting GITR and is in a clinical trial for solid tumours. - Rod57 (talk) 23:32, 25 June 2016 (UTC)